Heidelberg Pharma AG (HPHA.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:36PM CEST
| Previous close | 2.5500 |
| Open | 2.5900 |
| Bid | 2.5100 x N/A |
| Ask | 2.5900 x N/A |
| Day's range | 2.5100 - 2.5900 |
| 52-week range | 2.3000 - 4.0700 |
| Volume | |
| Avg. volume | 6,057 |
| Market cap | 120.707M |
| Beta (5Y monthly) | -0.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings date | 10 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Heidelberg Pharma Third Quarter 2024 Earnings: €0.13 loss per share (vs €0.002 profit in 3Q 2023)
Heidelberg Pharma ( ETR:HPHA ) Third Quarter 2024 Results Key Financial Results Revenue: €3.56m (up 59% from 3Q 2023...
Simply Wall St.With 46% ownership, Heidelberg Pharma AG (ETR:HPHA) insiders have a lot at stake
Key Insights Insiders appear to have a vested interest in Heidelberg Pharma's growth, as seen by their sizeable...
- Simply Wall St.
Shareholders in Heidelberg Pharma (ETR:HPHA) are in the red if they invested three years ago
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. But...